Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Appointed director

Merck & Co., Inc. (MRK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 291 options to buy @ $102.95, valued at $30k
10/03/2023 4 Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 79 options to buy @ $102.95, valued at $8.1k
10/03/2023 4 GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 437 options to buy @ $102.95, valued at $45k
10/03/2023 4 Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 291 options to buy @ $102.95, valued at $30k
08/15/2023 4 MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Sold 4,250 shares @ $109.01, valued at $463.3k
08/04/2023 4 Guindo Chirfi (Chief Marketing Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Exercised 36,901 shares @ $105.7, valued at $3.9M
Paid exercise price by delivering 17,989 shares @ $105.7, valued at $1.9M
Exercised 36,901 restricted stock units @ $0
08/04/2023 4 MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Sold 4,500 shares @ $105.4891, valued at $474.7k
08/03/2023 4 Romanelli Joseph (President, Human Health Int?l) has filed a Form 4 on Merck & Co., Inc.
Txns: Sold 30 shares @ $107.371, valued at $3.2k
Sold 59 shares @ $107.371, valued at $6.3k
07/05/2023 4 WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 260 options to buy @ $115.39, valued at $30k
07/05/2023 4 Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 70 options to buy @ $115.39, valued at $8.1k
07/05/2023 4 GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 390 options to buy @ $115.39, valued at $45k
07/05/2023 4 Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 260 options to buy @ $115.39, valued at $30k
06/30/2023 4 Romanelli Joseph (President, Human Health Int?l) has filed a Form 4 on Merck & Co., Inc.
Txns: Bought 59 shares @ $109.67, valued at $6.5k
Bought 107 shares @ $109.54, valued at $11.7k
Bought 30 shares @ $109.39, valued at $3.3k
Bought 56 shares @ $110.96, valued at $6.2k
Bought 7 shares @ $109.04, valued at $763.3
Bought 11 shares @ $109.2, valued at $1.2k
Bought 136 shares @ $105.47, valued at $14.3k
Sold 35 shares @ $104.65, valued at $3.7k
Bought 3 shares @ $113.68, valued at $341
05/31/2023 4 LAVIZZO-MOUREY RISA J (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 THULIN INGE G (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Warden Kathy J (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 RUSSO PATRICIA F (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Mayo Stephen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Craig Pamela J. (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 BAKER DOUGLAS M JR (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/05/2023 4 MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Exercised 13,000 shares @ $77.62, valued at $1M
Exercised 15,000 shares @ $75.36, valued at $1.1M
Exercised 12,000 shares @ $73.73, valued at $884.8k
Sold 13,000 shares @ $119.0086, valued at $1.5M
Sold 15,000 shares @ $119.0081, valued at $1.8M
Sold 12,000 shares @ $119.0074, valued at $1.4M
Exercised 12,000 shares @ $75.36, valued at $904.3k
Sold 13,400 shares @ $119.01, valued at $1.6M
Exercised 13,000 options to buy @ $0
Exercised 12,000 options to buy @ $0
Exercised 15,000 options to buy @ $0
05/05/2023 4 Zachary Jennifer (EVP, General Counsel) has filed a Form 4 on Merck & Co., Inc.
Txns: Sold 19,141 shares @ $117.5923, valued at $2.3M
05/05/2023 4 Oosthuizen Johannes Jacobus (President, U.S. Market) has filed a Form 4 on Merck & Co., Inc.
Txns: Exercised 907 shares @ $118.22, valued at $107.2k
Paid exercise price by delivering 447 shares @ $118.22, valued at $52.8k
Exercised 907 restricted stock units @ $0
05/05/2023 4 Klobuchar Michael A (EVP - Chief Strategy Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Exercised 885 shares @ $118.22, valued at $104.6k
Paid exercise price by delivering 436 shares @ $118.22, valued at $51.5k
Exercised 885 restricted stock units @ $0
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 4 Karachun Rita A (Sr. VP Fince-Global Controller) has filed a Form 4 on Merck & Co., Inc.
Txns: Exercised 803 shares @ $117.89, valued at $94.7k
Paid exercise price by delivering 276 shares @ $117.89, valued at $32.5k
Exercised 949 shares @ $118.22, valued at $112.2k
Paid exercise price by delivering 326 shares @ $118.22, valued at $38.5k
Sold 15,875 shares @ $117.5334, valued at $1.9M
Exercised 803 restricted stock units @ $0
Exercised 949 restricted stock units @ $0
Exercised 15,875 options to buy @ $62.07, valued at $985.4k
05/04/2023 4 LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 9,682 options to buy @ $117.89, valued at $1.1M
Granted 1,781 restricted stock units @ $0
05/04/2023 4 Karachun Rita A (Sr. VP Fince-Global Controller) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 9,682 options to buy @ $117.89, valued at $1.1M
Granted 1,781 restricted stock units @ $0
05/04/2023 4 Litchfield Caroline (EVP & CFO) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 58,783 options to buy @ $117.89, valued at $6.9M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy